515 filings
Page 5 of 26
8-K
l9g9060
1 Nov 18
Other Events
9:30am
8-K
slwe 8j4o
16 Oct 18
Changes in Control of Registrant
4:05pm
8-K
yfzaev6ptq xy3
12 Oct 18
Departure of Directors or Certain Officers
4:18pm
424B3
yx8xqaoyk65zx8nrr2ne
9 Oct 18
Prospectus supplement
4:16pm
8-K
i1ztz
28 Sep 18
Entry into a Material Definitive Agreement
4:00pm
424B3
na4oo
21 Sep 18
Prospectus supplement
4:16pm
8-K
a30jkcvq2up4legnor
7 Sep 18
Entry into a Material Definitive Agreement
12:00am
D
wck3x4 qq3f6kw9
17 Aug 18
$5.14M in equity, sold $5.14M, 13 investors
4:42pm
8-K
s3p8aci
3 Aug 18
Entry into a Material Definitive Agreement
9:30am
424B3
oh7mce68wec3j
3 Aug 18
Prospectus supplement
9:16am
8-K
vkg1wdq8vml2d31y
5 Jul 18
Entry into a Material Definitive Agreement
12:00am
8-K
ti78ur9kx2t
14 May 18
GT Biopharma Announces DR. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company
4:01pm
8-K
bdtqtjv1vhcr 06g7z70
27 Apr 18
Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors
4:01pm
EFFECT
suta5whqe
22 Mar 18
Notice of effectiveness
12:00am
EFFECT
unry87gwmm1ynti3
22 Mar 18
Notice of effectiveness
12:00am
CORRESP
xxa28zo jqm6vh2s45r9
21 Mar 18
Correspondence with SEC
12:00am
CORRESP
814b8
21 Mar 18
Correspondence with SEC
12:00am